REQUEST A DEMO
Total
USD $0.00
Search more companies

Galenika Ad Beograd (Serbia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Galenika Ad Beograd Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Galenika Ad Beograd is based in Serbia, with the head office in Belgrade. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on April 30, 1991. Galenika Ad Beograd currently employs 752 (2024) people. From the latest financial highlights, Galenika Ad Beograd reported a net sales revenue increase of 10.25% in 2024. A growth of 18.58% was recorded in its total assets. In 2024, Galenika Ad Beograd’s net profit margin decreased by 7.19%.

Headquarters
Batajnicki Drum bb
Belgrade; Belgrade;

Contact Details: Purchase the Galenika Ad Beograd report to view the information.

Website: http://www.galenika.co.rs

Basic Information
Total Employees:
Purchase the Galenika Ad Beograd report to view the information.
Outstanding Shares:
Purchase the Galenika Ad Beograd report to view the information.
Registered Capital:
Purchase the Galenika Ad Beograd report to view the information.
Financial Auditors:
Purchase the Galenika Ad Beograd report to view the information.
Incorporation Date:
April 30, 1991
Key Executives
Purchase this report to view the information.
Acting General Director
Subsidiaries
Galenika-Klirit D.O.O. Beograd (Zemun)
100%
Galing D.O.O. Beograd
100%
Lifemedic D.O.O. Beograd
100%
Company Performance
Financial values in the chart are available after Galenika Ad Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
10.25%
Total Operating Revenue
-0.78%
Operating Profit
-28.22%
EBITDA
-21.42%
Net Profit/Loss for the Period
-35.44%
Total Assets
18.58%
Total Equity
7.19%
Operating Profit Margin
-7.66%
Net Profit Margin
-7.19%
Return on Equity (ROE)
-5.71%
Debt / Equity
13.37%
Quick Ratio
0.08%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?